Literature DB >> 24706917

Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis.

Vincent S Tagliabracci1, James L Engel, Sandra E Wiley, Junyu Xiao, David J Gonzalez, Hitesh Nidumanda Appaiah, Antonius Koller, Victor Nizet, Kenneth E White, Jack E Dixon.   

Abstract

The family with sequence similarity 20, member C (Fam20C) has recently been identified as the Golgi casein kinase. Fam20C phosphorylates secreted proteins on Ser-x-Glu/pSer motifs and loss-of-function mutations in the kinase cause Raine syndrome, an often-fatal osteosclerotic bone dysplasia. Fam20C is potentially an upstream regulator of the phosphate-regulating hormone fibroblast growth factor 23 (FGF23), because humans with FAM20C mutations and Fam20C KO mice develop hypophosphatemia due to an increase in full-length, biologically active FGF23. However, the mechanism by which Fam20C regulates FGF23 is unknown. Here we show that Fam20C directly phosphorylates FGF23 on Ser(180), within the FGF23 R(176)XXR(179)/S(180)AE subtilisin-like proprotein convertase motif. This phosphorylation event inhibits O-glycosylation of FGF23 by polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3), and promotes FGF23 cleavage and inactivation by the subtilisin-like proprotein convertase furin. Collectively, our results provide a molecular mechanism by which FGF23 is dynamically regulated by phosphorylation, glycosylation, and proteolysis. Furthermore, our findings suggest that cross-talk between phosphorylation and O-glycosylation of proteins in the secretory pathway may be an important mechanism by which secreted proteins are regulated.

Entities:  

Keywords:  Fam20; chronic kidney disease; familial tumoral calcinosis; phosphate homeostasis; rickets

Mesh:

Substances:

Year:  2014        PMID: 24706917      PMCID: PMC3992636          DOI: 10.1073/pnas.1402218111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteome.

Authors:  Mauro Salvi; Luca Cesaro; Elena Tibaldi; Lorenzo A Pinna
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

2.  Expression of FAM20C in the osteogenesis and odontogenesis of mouse.

Authors:  Xiaofang Wang; Jianjun Hao; Yixia Xie; Yao Sun; Brianda Hernandez; Albert K Yamoah; Monica Prasad; Qinglin Zhu; Jian Q Feng; Chunlin Qin
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

Review 3.  Recent advances in renal phosphate handling.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 4.  Location, location, location: new insights into O-GalNAc protein glycosylation.

Authors:  David J Gill; Henrik Clausen; Frederic Bard
Journal:  Trends Cell Biol       Date:  2010-12-08       Impact factor: 20.808

Review 5.  Iron-sensing proteins that regulate hepcidin and enteric iron absorption.

Authors:  Mitchell D Knutson
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

6.  Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.

Authors:  Bettina Lorenz-Depiereux; Dirk Schnabel; Dov Tiosano; Gabriele Häusler; Tim M Strom
Journal:  Am J Hum Genet       Date:  2010-02-04       Impact factor: 11.025

Review 7.  Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

8.  Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis.

Authors:  Clemens Bergwitz; Santanu Banerjee; Hilal Abu-Zahra; Hiroshi Kaji; Akimitsu Miyauchi; Toshitsugu Sugimoto; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

9.  Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9.

Authors:  Elena Tibaldi; Giorgio Arrigoni; Heather M Martinez; Kenichi Inagaki; Shunichi Shimasaki; Lorenzo A Pinna
Journal:  FEBS Lett       Date:  2010-01-12       Impact factor: 4.124

10.  Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia.

Authors:  M A Simpson; A Scheuerle; J Hurst; M A Patton; H Stewart; A H Crosby
Journal:  Clin Genet       Date:  2009-03       Impact factor: 4.438

View more
  117 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.

Authors:  Eva S Liu; Janaina S Martins; Adalbert Raimann; Byongsoo Timothy Chae; Daniel J Brooks; Vanda Jorgetti; Mary L Bouxsein; Marie B Demay
Journal:  J Bone Miner Res       Date:  2016-02-02       Impact factor: 6.741

Review 3.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

4.  Immortalized Mouse Floxed Fam20c Dental Papillar Mesenchymal and Osteoblast Cell Lines Retain Their Primary Characteristics.

Authors:  Chao Liu; Xiaofang Wang; Hua Zhang; Xiaohua Xie; Peihong Liu; Ying Liu; Priyam H Jani; Yongbo Lu; Shuo Chen; Chunlin Qin
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

5.  1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.

Authors:  Janaina S Martins; Eva S Liu; W Bruce Sneddon; Peter A Friedman; Marie B Demay
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

6.  Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy.

Authors:  Julia M Hum; Linda M O'Bryan; Arun K Tatiparthi; Erica L Clinkenbeard; Pu Ni; Martin S Cramer; Manoj Bhaskaran; Robert L Johnson; Jonathan M Wilson; Rosamund C Smith; Kenneth E White
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

Review 7.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

8.  Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions.

Authors:  Shengjun Wang; Yang Mao; Yoshiki Narimatsu; Zilu Ye; Weihua Tian; Christoffer K Goth; Erandi Lira-Navarrete; Nis B Pedersen; Asier Benito-Vicente; Cesar Martin; Kepa B Uribe; Ramon Hurtado-Guerrero; Christina Christoffersen; Nabil G Seidah; Rikke Nielsen; Erik I Christensen; Lars Hansen; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager; Henrik Clausen
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

Review 9.  Non-renal-Related Mechanisms of FGF23 Pathophysiology.

Authors:  Mark R Hanudel; Marciana Laster; Isidro B Salusky
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 10.  Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions.

Authors:  L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.